| Bioactivity | Luciferase activator-1 (Compound D2) is an activator for luciferase, which increases the luciferase activity up 1.04 fold (at the concentration of 50 nM)[1]. | ||||||||||||
| CAS | 315703-95-8 | ||||||||||||
| Formula | C19H21N5S2 | ||||||||||||
| Molar Mass | 383.53 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Leone S, et al., SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington's disease. Bioorg Med Chem. 2008 May 15;16(10):5695-703. |
Luciferase activator-1
CAS: 315703-95-8 F: C19H21N5S2 W: 383.53
Luciferase activator-1 (Compound D2) is an activator for luciferase, which increases the luciferase activity up 1.04 fol
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.